United States · FDA National Drug Code directory
Ranolazine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72578-065_ca6a476b-e330-4618-8661-08ac1125fc3e
- Product NDC
- 72578-065
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Ranolazine
- Labeler
- Viona Pharmaceuticals Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190910
- Source listing expiry
- 20271231
Source-listed ingredients
- RANOLAZINE — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72578-065-01) · 72578-065-01
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72578-065-05) · 72578-065-05
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (72578-065-14) · 72578-065-14
- 10 BLISTER PACK in 1 CARTON (72578-065-77) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (72578-065-30) · 72578-065-77
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →